Back

GRK2 is a novel early marker of cardiotoxicity in response to doxorubicin

26 May 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Basic Science - Autoimmune/Chronic Inflammatory Disorders and Heart Disease Autoimmune/Chronic Inflammatory Disorders and Heart Disease HFA Premium Access Heart Failure 2018

About the speaker

Photo
Doctor Matteo De Rosa

G. d Annunzio University, Chieti (Italy)

Access the full session

Session thumbnail
Poster Session 3 - Basic Science - Autoimmune/Chronic Inflammatory Disorders and Heart Disease

The Event

Event poster

Heart Failure 2018

26 May - 29 May 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources